Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001062993-26-000816·Saba Capital Management, L.P.
Schedule 13D ownership disclosure
ABRDN LIFE SCIENCES INVESTOR
Common Shares, $0.01 par value · CUSIP: 87911K100
Event date: 2026-02-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Saba Capital Management, L.P.Reported CIK 0001510281
Shares: 1,686,997 · Class: 5.7%
- Boaz R. WeinsteinReported CIK 0001608233
Shares: 1,686,997 · Class: 5.7%
- Saba Capital Management GP, LLC
Shares: 1,686,997 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-26-000816
- Form type
- SCHEDULE 13D/A
- Filer
- Saba Capital Management, L.P.
- CIK
- CIK 1510281
- Filed
- Feb 11, 2026
- Reporting period
- Feb 09, 2026
- Description
- Schedule 13D beneficial ownership